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DBackground:Available data on the long-term renal outcome of patients who required renal replacement therapy
after cardiac surgery for correction of congenital cardiac anomalies are scarce. The aim of the present study was
to investigate the long-term renal prognosis of children treated with peritoneal dialysis after surgical correction
of congenital heart anomalies.
Methods: The present single-center cohort study was based on clinical data from patients who underwent
surgery for the correction of congenital heart disease between 1996 and 2004 at the Schneider’s Children’s
Medical Center of Israel, and developed acute kidney injury (AKI) requiring peritoneal dialysis. Perioperative
risk factors were analyzed. Survivors were followed up for 3.5 to 10.5 years after their surgery. Renal function
was assessed in survivors by physical examination, including blood pressure, growth evaluation, urinalysis,
glomerular filtration rate estimated from plasma creatinine using the Schwartz formula, and ultrasonographic
examination of the kidneys.
Results: There were 2994 children who underwent surgery during the study period. Eighty-four children
(2.84%) developed postoperative AKI that was managed with peritoneal dialysis. Seventy-six children were
included in our study, 8 were excluded because of a lack of complete data. Of the 76 children included,
35 died during the immediate postoperative period, 15 died during the interim of nonrenal causes, and
26 were alive at the time of follow-up evaluation. Twenty-five patients with a complete evaluation had blood
pressure measurements in the normal range. Plasma creatinine levels were normal for age. Only 1 child,
who had a pre-existing congenital renal anomaly, had an abnormal glomerular filtration rate. None of the
children had proteinuria. Three children were treated with angiotensin-converting enzyme inhibitors and
2 were treated with furosemide for congestive heart failure. We found no risk factors associated with immediate
postoperative death.
Conclusions: Despite the development of AKI requiring dialysis after surgical correction of congenital cardiac
anomalies, the long-term renal prognosis in survivors is good. (J Thorac Cardiovasc Surg 2014;147:451-5)Acute kidney injury (AKI) is a frequent and serious compli-
cation of cardiac surgery. Reported rates of patients who
require renal replacement therapy after open heart surgery
range from 1.6% to 7.7%.1-5 The mechanism of the
renal injury involves both postischemic (preoperative,
operative, and postoperative low cardiac output) and toxic
(contrast media for diagnostic cardiac catheterization,
nephrotoxic drugs, myoglobin, and so forth) factors.
Peritoneal dialysis is the preferred treatment, and
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The Journal of Thoracic and Caa Tenckhoff catheter at the conclusion of complicated
cardiac procedures.3-7 This is particularly important in
young children in whom vascular access may become
problematic and complicate the use of hemofiltration.5,6
Children who develop AKI for various reasons requiring
renal replacement therapy are known to be at high risk for re-
sidual kidney damage.8 Most of the rather large number of
publications published to date have focused on the short-
term outcome of children who required peritoneal dialysis
after cardiac surgery.3-7,9 The overall short-term mortality
rates reported in these studies ranged from 50% to 60% in
earlier studies4 to only 20% in later studies.8 To date, only
1 study attempted to discern the long-term renal outcome
of those patients who required renal replacement therapy.
The study conducted more than 20 years ago by Shaw
et al10 described the renal function 1 to 5 years after dis-
charge of a total of 11 long-term survivors.
The aim of the present study was to investigate the long-
term renal outcome of children treated with peritoneal dial-
ysis after cardiac surgery for the correction of congenital
anomalies.rdiovascular Surgery c Volume 147, Number 1 451
Abbreviations and Acronyms
AKI ¼ acute kidney injury
GFR ¼ glomerular filtration rate
pRIFLE ¼ pediatric risk, injury, failure, loss,
end-stage renal disease
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DMATERIALS AND METHODS
The medical files of all patients who underwent surgery for congenital
heart disease from 1996 to 2004 at a tertiary pediatric medical center were
reviewed. All patients who developed AKI requiring renal replacement
therapy with peritoneal dialysis were included in our study.
After children undergo cardiac surgery at our center, dialysis is
performed with a standard double-cuffed Tenckhoff catheter inserted
during surgery or just before initiation of dialysis. Commercially available
peritoneal dialysis fluids are infused via a simple closed system; the
dialysate later is drained mechanically through the indwelling catheter
into a collecting device. For the present study, we recorded the indications
for, in addition to data on potential preoperative, intraoperative, and
postoperative risk factors for, immediate and long-term mortality.
Preoperative Risk Factors
The preoperative risk factors evaluated were the type of cardiac
malformation, preoperative cardiac catheterization, use of diuretics
(specifically furosemide), use of prostaglandins, need for vasopressor
treatment, and other medications. The preoperative glomerular filtration
rate (GFR) was calculated using the Schwartz11 formula. Other congenital
malformations and syndromes were recorded as well.
Intraoperative Risk Factors
To define the complexity and risk of each procedure, we used the Risk
Adjusted Classification for Congenital Heart Surgery, which has been
proven valid and accurate.12,13 Other intraoperative risk factors that were
evaluated were length of time on cardiopulmonary bypass, aortic
cross-clamp time, lowest body temperature during surgery, and open or
closed sternal cavity at the end of surgery.
Postoperative Risk Factors
The postoperative risk factors evaluated were medical treatment
(mainly inotropic medications and furosemide), cardiopulmonary
resuscitation, extracorporeal membrane oxygenation, and significant
arrhythmias, defined as any of the following: ventricular tachycardia,
ventricular fibrillation, supraventricular tachycardia, junctional ectopic
tachycardia, or use of an external pacemaker.
Dialysis Initiation
In our study we looked at reasons for dialysis initiation, the interval
between the surgical procedure and dialysis initiation and the length of
dialysis, to see if any of these factors affected survival. We also examined
peek creatinine and urea levels. We used the modified pediatric risk, injury,
failure, loss, end-stage renal disease (pRIFLE) criteria14 to categorize and
stratify the degree of renal injury at the time of dialysis initiation.
The patients were divided into 3 groups by outcome: those who died
immediately after surgery, those who died after discharge, and those who
were still alive during the present study. The parents of all survivors
were contacted and invited to bring their child to the clinic for evaluation
of renal function. Our study was approved by the hospital institutional
review board and was performed in accordance with the Declaration of
Helsinki. After written informed consent was obtained, physical examina-
tion, including measurement of blood pressure, growth evaluation,452 The Journal of Thoracic and Cardiovascular Surgurinalysis, estimation of GFR from plasma creatinine level according to
the Schwartz11 formula, and renal ultrasound were performed.
Statistical Analysis
The data were analyzed using BMDP Software (Los Angeles, Calif).15
Continuous variableswere analyzedbyoutcomeusing1-wayanalysis of var-
iance, and discrete variables were analyzed using the Pearson chi-square test
or the Kruskal-Wallis test, as appropriate. Kaplan-Meier survival estimates
were calculated. A P value of .05 or less was considered significant.
RESULTS
Of the 2994 patients who underwent surgery at our center
between 1996 and 2004 to correct a congenital cardiac anom-
aly, 84 (2.8%) had severe postoperativeAKI andwere treated
with peritoneal dialysis. Eight patients were excluded from
the study because of a lack of follow-up data. These included
2 patients who transferred to another hospital and 2 patients
who left the country. The remaining 76 patients formed the
study group. Thirty-five patients (46%) died immediately af-
ter surgery, 15patients (20%) died after discharge, and 26pa-
tients (34%) survived to the present study.
The cohort consisted of 40boys (52%) and36girls (48%),
with a median age of 45 days at surgery and a median weight
of 3.47 kg (range, 1.6-71 kg). There was no statistically sig-
nificant difference between the outcome groups in back-
ground characteristics or indications for dialysis (Table 1).
Preoperative Risk Factors
Forty-six patients (61.3%) had a cyanotic heart malfor-
mation, of whom 21 died in the immediate postoperative
period, 8 died after discharge, and 17 survived (P ¼ .9;
95% confidence interval  0.1). Twenty-three patients un-
derwent cardiac catheterization before surgery, usually (20
patients) to perform a Rushkind procedure.
Fifteen of the 76 patients (19.7%) had a syndromic or
chromosomal abnormality, namely trisomy 21 (8 patients),
22q11.2 deletion (DiGeorge/velocardiofacial syndrome,
4 patients), 4P deletion (Wolf Hirschhorn syndrome,
1 patient), Kabuki syndrome (1 patient), and VACTER
(vertebral defects, anal atresia, cardiac defects, tracheoeso-
phageal fistula, renal anomalies) association (1 patient).
Nine patients (11.8%) had pre-existing congenital renalmal-
formations that were identified on the preoperative renal
ultrasound examination: horseshoe kidney (4 patients), bilat-
eral mild pyelectasis (2 patients), right dysplastic kidney
(1 patient), pelvic kidney (1 patient), and leftmulticystic dys-
plastic kidney with right ectopic kidney (1 patient). The
number of patients with renal malformations was too small
to ascertain the effect of renal malformations on survival.
The most frequent preoperative medications used were
furosemide (46% of patients), prostaglandins (36.8%; to
maintain a patent ductus arteriosus), and vasopressors
(26.3%). There was no significant difference among the
3 groups regarding the use of prostaglandins or vasopressors
(Table 1). Other medications included amiodarone,ery c January 2014
TABLE 1. Characteristics of dialysis procedure and risk factors in 76 patients after cardiac surgery for correction of congenital anomalies, by
outcome
Characteristic
Died immediately
postoperatively (n ¼ 35)
Died after
discharge (n ¼ 15)
Survived
(n ¼ 26) P value
Sex (male), n (%) 16 (47) 8 (53) 15 (57) .64
Median age (y) 0.15 0.06 0.12 .547
Median weight (kg) 3.58 3.25 3.45 .610
Preoperative risk factors
Cyanosis, n (%) 21 (60) 8 (53) 17 (65) .9
Cardiac catheterization, n (%) 11 (31) 5 (33) 7 (27) .95
Diuretics, n (%) 22 (62.8) 4 (26.7) 9 (34.6) .07
Inotropic drugs, n (%) 12 (34) 4 (28) 4 (15) .25
Prostaglandin E2 drugs, n (%) 12 (34) 6 (40) 10 (38.5) .46
Median preoperative estimated GFR, mL/min 45 31 38 .32
Surgical risk factors
Median RACHS score 3.61 3.6 3.46 .537
Median cardiopulmonary bypass time (min) 168 194 164 .844
Median aortic cross-clamp time (min) 112.5106 117 100 .985
Median lowest temperature (C) 25 25 26 .871
Postoperative risk factors
Cardiac arrest, n (%) 11 (31.4) 4 (26.6) 4 (15.4) .12
ECMO, n (%) 7 (20) 2 (13.3) 4 (15.4) .83
Arrhythmia, n (%) 10 (28.6) 9 (60) 10 (38.4) .11
Treatment
Dopamine,% 97 87 92 .383
Adrenaline,% 85.70 73 80 .576
Milrinone,% 68.60 47 60 .34
Dialysis characteristics
Median time to dialysis (h) 55 32.8 43.6 .886
Median length of dialysis (d) 5.6 4.6 5.96 .406
Reason for dialysis
Fluid overload, n (%) 34 (97) 15 (100) 24 (92) .4
Acid-base disturbance, n (%) 11 (31.4) 2 (13.3) 4 (15.4) .23
Hyperkalemia, n (%) 7 (20) 0 4 (15.4) .18
Median peak creatinine level, mg/dL 1.55 1.4 1.5 .836
Median estimated GFR at dialysis initiation 14.9 11 12 .704
ECMO, Extracorporeal membrane oxygenation; RACHS, Risk Adjusted Classification for Congenital Heart Surgery; GFR, glomerular filtration rate.
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Dverapamil, angiotensin-converting enzyme inhibitors,
b-blockers, aspirin, ranitidine, warfarin, and systemic ste-
roids. None of these was given frequently enough to evalu-
ate statistical differences.
Intraoperative Risk Factors
The median Risk Adjusted Classification for Congenital
Heart Surgery score for the whole study sample was
3.62, with no significant difference among the 3 outcome
groups (P ¼ .537; 95% confidence interval  0.2). There
was also no statistically significant difference among the
groups in bypass time, aortic cross-clamp time, or lowest
measured temperature (Table 1).
Postoperative Risk Factors
All of the patients required inotropic support. Dopamine
was administered in 93.3% of patients, and adrenaline was
administered in 81.3%, with no difference among theThe Journal of Thoracic and Caoutcome groups (Table 1). All patients were treated with
furosemide after surgery.
There was no significant difference in the rate of cardiac
arrhythmias among the 3 groups (P ¼ .11). Thirteen
patients required extracorporeal membrane oxygenation,
with no significant difference among the groups.
Dialysis
The indications for peritoneal dialysis were clinical fluid
overload with or without concurrent oliguria or anuria,
hyperkalemia, or an acid-base disturbance that could not
otherwise be treated. In addition, the time of initiation and
the duration of dialysis were similar in all 3 groups, as
were peak creatinine levels (Table 1) and the degree of
AKI as assessed by the pRIFLE criteria.14 All of our
patientsmet the pRIFLEcriteria for failure according to their
estimated GFR levels. The median estimated GFR was
13 mL/min/1.73 m2 at dialysis initiation and there was nordiovascular Surgery c Volume 147, Number 1 453
Congenital Heart Disease Mel et al
C
H
Dstatistical difference between the groups (P ¼ .704; 95%
confidence interval  0.2).
Long-Term Follow-up Evaluation
Of the 76 patients included in the study, 26 were alive at
the time of this study. The parents of 25 patients consented
to follow-up evaluation (Table 2). The interval from surgery
to the clinic visit was 3.5 to 11 years, with a median interval
of 5.15 years. Blood pressure in all 25 patients was below
the 90th percentile for age and height. Plasma creatinine
level was within normal range for age. The GFR was abnor-
mal in only 1 patient, who had a pre-existing right multicys-
tic dysplastic kidney and a left ectopic kidney. Three
children were being treated with angiotensin-converting en-
zyme inhibitors and 2 were being treated with furosemide
(for congestive heart failure). Urinalysis was normal in all
patients; none of the patients had proteinuria. In the patients
who did not have a pre-existing renal malformation, renalTABLE 2. Characteristics of 25 long-term survivors
Age at follow-up
evaluation (y)
Weight
(kg)
Weight
SDS
Height
(cm)
Height
SDS
Estim
GF
10.5 20 3.09 119 3.35 11
8.3 16 2.5 115 3.86 9
11.3 27 1.83 127 2.6 20
9.1 28 0.15 130 0.65 15
8.9 20 2.4 122 1.77 15
23.2 78 1.89 173 1.52 14
9.5 30 0.04 131 0.81 15
11.5 32 0.76 140 0.83 13
6.7 20 0.72 112 1.47 12
6.5 23 0.38 119 0.01 14
7.5 23 0.39 114 1.94 14
6.1 16 1.98 106 2.03 13
5.9 19 0.46 113 0.36 17
4.5 14.5 1.68 99 1.62 19
5.1 18 0.35 108 0.21 12
5.1 15 1.4 103 1.34 22
31.0 77.5 1.85 152 1.9 16
4.9 12.5 3.59 100 1.98 13
4.3 14 1.51 95 2.1 8
4.5 16 0.93 102 0.8 14
5.3 15.1 1.79 100 2.38 10
11.8 30 1.38 130 2.44 16
3.1 14 0.54 90 1.68 13
3.3 11 2.66 85 3.13 9
3.5 15 0.1 98 0.03 14
GFR, Glomerular filtration rate; SDS, standards of deviations.
454 The Journal of Thoracic and Cardiovascular Surgsonography showed no abnormalities in renal size, paren-
chymal structure, or collecting system.
DISCUSSION
The aim of the present study was to evaluate the long-
term renal effects of AKI requiring dialysis after surgery
for the correction of congenital cardiac malformations.
Since the previous long-term study in this setting,10 many
advances have been made in surgical and critical care
techniques, as well as in renal replacement therapy.
In the present study, which covered the period from 1996
to 2004, the complexity of the cardiac surgeries, including
the type and distribution of the syndromic/chromosome
abnormalities, the time of initiation and duration of dialysis,
and the overall morbidity andmortality rates, were similar to
those reported in earlier short-term follow-up studies.2-8 A
total of 2.8% of consecutive patients who underwent
cardiac surgery developed AKI requiring peritonealated
R Renal Sonography Treatment
4 Normal
7 Aspirin
2 Normal Aspirin, valproic acid,
lamotrigine
9 Normal
6 Normal
9 Normal Warfarin
2 Normal Warfarin
6 Normal
8
3 Normal
2 Horseshoe kidney Captopril
4 Normal Captopril
2 Horseshoe kidney Captopril, digoxin,
furosumide, aspirin
8
6 Normal
6
3 Left kidney, normal; right
kidney, normal size with
increased echogenicity,
type 1
4 Normal
5 Right multicystic dysplastic
kidney and left ectopic
kidney
4 Normal Aspirin, furosumide, digoxin
5 Normal Aspirin, spironolactone,
furosumide
5 Normal
1 Normal
9 Normal Aspirin
9 Normal
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Ddialysis, a rate very similar to rates reported by other large
centers during those years.2-7 In our cohort of 76 patients,
the initial short-term mortality rate was 46%, which also
was very similar to the short-term mortality described in
those studies. In addition, in linewith these studies, we found
no statistically significant difference between the patients
who died immediately after surgery, the short-term survivors
(who died after discharge), and the long-term survivors in
preoperative, operative, or postoperative risk factors.
By the time of the study in June 2007, 26 of the 76 patients
were alive, for anoverallmortality rate of 65.7%. The interim
mortality rate of nearly 20%most likely was attributed to the
severity of the initial cardiac malformation and/or syndrome.
Some of the deaths occurred during additional procedures for
the correction of the cardiac malformation. Through the use
of a national registry for patients we know that none of
them required dialysis after these procedures and that none
of the deaths were caused by renal failure. In the only other
study of long-term mortality, Shaw et al10 reported no
intermediate-term deaths. Their short-term mortality rate
was 68%, with all 11 survivors available for follow-up eval-
uation 1 to 5 years after discharge. Two of the 11 survivors
had renal complications (low GFR or proteinuria).
In our study, conducted 3.5 to 11 years after discharge
(median, 5.15 y), in all 26 long-term survivors evaluated,
the overall renal function as assessed by systolic and
diastolic blood pressure was below the 90th percentile for
age and height and GFR was within the normal range.
The sole patient with an abnormal GFR had a pre-existing
congenital right multicystic dysplastic kidney and a small
left ectopic kidney. Proteinuria, which we used as an
additional marker of glomerular damage, was not found
in any of the patients. Angiotensin-converting enzyme
inhibitors were used by 3 patients, but in all 3 the indication
was congestive heart failure, not hypertension. We believe
that the lack of long-term residual kidney damage probably
is related to the predominant hemodynamic mechanism of
the AKI, leading to an impairment that was reversible in
those patients who survived cardiac surgery.
Our study had several limitations. GFR both in the
perioperative period and the follow-up periodwas calculated
using the Schwartz11 formula and was not measured directly
using either inulin clearanceor nuclearmedicine–basedGFR
scans, which are considered the gold standard. However, this
is an acceptable and frequently used method in both clinical
and research settings. Furthermore, we originally intended to
assess glomerular function bymeasuring renal functional re-
serve16 on the basis of earlier studies showing that patients
with previous acute renal failure have a diminished renal
functional reserve despite normal renal function.17 However,
we were unable to do so mainly because of issues of patient
consent and could perform only a general urinalysis.
There was insufficient data to assess the renal function of
those patients who died in the interim period because mostThe Journal of Thoracic and Calate deaths did not occur at our institution. We do know that
none of them suffered from severe renal failure and that
none required renal replacement therapy through the use
of a national registry. We cannot, however, rule out the
possibility of mild to moderate renal dysfunction as
a contributing factor to death.
It also should be noted that in our cohort the number of
patients with pre-existing renal malformation was relatively
large (11.8%). We believe it prudent to perform renal
sonography and glomerular function evaluation before
complicated cardiac procedures. Further studies are needed
to examine this question.
In conclusion, the need for peritoneal dialysis for acute
renal failure after surgery to correct congenital cardiac
anomalies is not associated with a poor renal prognosis in
long-term survivors.References
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